China Knowledge @ Wharton has put up a stellar interview with Xu Lianjie, CEO of HengAn International Group (HA Group), China’s largest paper products manufacturer and recent acquirer of QinQin Foodstufs (hence the feature photo with Xu Lianjie on the left, posing next to food products). HA Group, is a true conglomerate giant, with “a [...]

In the April-June issue of China Business Review, I have an article published on China’s senior care market.  Designed to shed light on the regulatory, cultural and contextual challenges American eldercare operators will face when expanding into China, the article focuses on five key challenges:  the perceived value of the services provided as judged by [...]

            Last week I had the pleasure to sit down with Cole Wright of Merrill Gardens.  Cole is heading up the project at Merrill Gardens to develop their first eldercare facility in China.  Perhaps the most interesting dimension to our conversation was Cole’s emphasis on the challenge of actually implementing an eldercare operation in China. [...]

Part of what we hope to do here at the AsiaHealthcareBlog is go a bit deeper beyond a pure presentation of the opportunities in China for the biotech / pharma / medical device space.  While talking about the general opportunities available for companies in China, we want to explore in more detail the structural, cultural [...]

     Few issues are more critical to determining the success or failure of eldercare businesses in China than the role of filial piety in Chinese culture.  In a historical sense, the pressing cultural reality that many Chinese will not be able to provide the same sort of in-home care for their parents as the generation [...]

             The easiest – and admittedly also the most misleading – justification for going to China with your new healthcare business idea is the country’s demographic trends.  The sheer population size of the country makes a compelling case for believing that whatever other unknowns and uncertainties your business model will need to adapt itself to, [...]

Earlier this year as part of an advisory board I sit on, we traveled to China to see a host of companies who are successfully operating in the country.  One of those that stuck most in my head was Crown Biosciences.  Started by a group of top-notch pharmaceutical leaders from the United States, the management [...]

If you are interested in learning more about China’s healthcare system, a couple of conferences should probably be on your radar screen.   The first, BioChina, is in Shanghai October 12-13; from the program it looks to be a great insight into the current status of China’s pharmaceutical industry, its regulatory regime in life sciences [...]